1. Home
  2. INBX
  3. INBX News

Latest Inhibrx Inc. (INBX) News on May 14, 2025

INBX

MT Newswires

a month ago

Inhibrx Biosciences Signs Deal With Outgoing CSO Brendan Eckelman's New Venture

Inhibrx Biosciences Announces Departure of CSO and Appointments of New CSO and President
INBX

PR Newswire

a month ago

Inhibrx Biosciences Announces Departure of CSO and Appointments of New CSO and President

Inhibrx Biosciences Full Year 2024 Earnings: Beats Expectations
INBX

Simply Wall St.

2 months ago

Inhibrx Biosciences Full Year 2024 Earnings: Beats Expectations

Inhibrx Reports Fourth Quarter and Fiscal Year 2024 Financial Results
INBX

PR Newswire

2 months ago

Inhibrx Reports Fourth Quarter and Fiscal Year 2024 Financial Results

INBX

MT Newswires

4 months ago

Inhibrx Prospective Colorectal Cancer Treatment Shows Encouraging Results, Trial Expansion Planned

Inhibrx Biosciences Announces Preliminary Data from the Phase 1 Trial of ozekibart (INBRX-109) for the Treatment of Colorectal Cancer
INBX

PR Newswire

4 months ago

Inhibrx Biosciences Announces Preliminary Data from the Phase 1 Trial of ozekibart (INBRX-109) for the Treatment of Colorectal Cancer

Inhibrx Biosciences Announces Loan Agreement with Oxford Finance
INBX

PR Newswire

4 months ago

Inhibrx Biosciences Announces Loan Agreement with Oxford Finance

INBX

MT Newswires

6 months ago

Inhibrx Biosciences Insider Bought Shares Worth $1,523,620, According to a Recent SEC Filing

The recent drop in prices must have disappointed Inhibrx Biosciences, Inc. (NASDAQ:INBX) institutional investors who own 43% of the shares
INBX

Simply Wall St.

6 months ago

The recent drop in prices must have disappointed Inhibrx Biosciences, Inc. (NASDAQ:INBX) institutional investors who own 43% of the shares

Inhibrx Biosciences Reports Third Quarter 2024 Financial Results
INBX

PR Newswire

6 months ago

Inhibrx Biosciences Reports Third Quarter 2024 Financial Results

Inhibrx Prevails in Trade Secret Case, Reaffirming Its Commitment to Integrity and Innovation
INBX

PR Newswire

6 months ago

Inhibrx Prevails in Trade Secret Case, Reaffirming Its Commitment to Integrity and Innovation

INBX

Argus Research

7 months ago

Daily – Vickers Top Buyers & Sellers for 10/08/2024

INBX

MT Newswires

8 months ago

Inhibrx Biosciences Insider Bought Shares Worth $629,117, According to a Recent SEC Filing

INBX

GuruFocus.com

8 months ago

Director Kristiina Vuori Purchases Shares of Inhibrx Biosciences Inc (INBX)

INBX

MT Newswires

9 months ago

Inhibrx Biosciences Insider Bought Shares Worth $1,037,328, According to a Recent SEC Filing

Inhibrx Biosciences Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights
INBX

PR Newswire

9 months ago

Inhibrx Biosciences Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights

INBX

MT Newswires

a year ago

Inhibrx Biosciences Insider Bought Shares Worth $4,927,580, According to a Recent SEC Filing

INBX

MT Newswires

a year ago

Inhibrx Shareholders Approve Sale of INBRX-101 Assets to Sanofi

Inhibrx Inc. Stockholders Approve Sale of INBRX-101 to Sanofi
INBX

PR Newswire

a year ago

Inhibrx Inc. Stockholders Approve Sale of INBRX-101 to Sanofi

Inhibrx, Inc. Announces Updated When-Issued Trading Date for Anticipated Spin-Off
INBX

PR Newswire

a year ago

Inhibrx, Inc. Announces Updated When-Issued Trading Date for Anticipated Spin-Off

Inhibrx, Inc. Announces Record Date and Expected Distribution Time for Anticipated Spin-Off and the Expected Merger Effective Time for Anticipated Merger
INBX

PR Newswire

a year ago

Inhibrx, Inc. Announces Record Date and Expected Distribution Time for Anticipated Spin-Off and the Expected Merger Effective Time for Anticipated Merger

Inhibrx, Inc. (INBX) Reports Q4 Loss, Tops Revenue Estimates
INBX

Zacks

a year ago

Inhibrx, Inc. (INBX) Reports Q4 Loss, Tops Revenue Estimates

Inhibrx Reports Fourth Quarter and Fiscal Year 2023 Financial Results
INBX

PR Newswire

a year ago

Inhibrx Reports Fourth Quarter and Fiscal Year 2023 Financial Results

Will Corcept (CORT) Beat Estimates Again in Its Next Earnings Report?
INBX

Zacks

a year ago

Will Corcept (CORT) Beat Estimates Again in Its Next Earnings Report?

SoFi Stock Soars After Company Posts First-Ever Quarterly Profit
INBX

Barrons.com

a year ago

SoFi Stock Soars After Company Posts First-Ever Quarterly Profit

Gabelli Funds to Host Pump, Valve & Water Systems Symposium at The Yale Club, New York, NY
INBX

GlobeNewswire

a year ago

Gabelli Funds to Host Pump, Valve & Water Systems Symposium at The Yale Club, New York, NY

Forget Palantir: 2 Artificial Intelligence (AI) Stocks to Buy Instead
INBX

Motley Fool

a year ago

Forget Palantir: 2 Artificial Intelligence (AI) Stocks to Buy Instead

Gentex Corporation (NASDAQ:GNTX) Q4 2023 Earnings Call Transcript
INBX

Insider Monkey

a year ago

Gentex Corporation (NASDAQ:GNTX) Q4 2023 Earnings Call Transcript

Pharma Stock Roundup: JNJ Reports Q4 Earnings, SNY Inks M&A Deal With INBX
INBX

Zacks

a year ago

Pharma Stock Roundup: JNJ Reports Q4 Earnings, SNY Inks M&A Deal With INBX

Sensient Technologies (NYSE:SXT) Has Affirmed Its Dividend Of $0.41
INBX

Simply Wall St.

a year ago

Sensient Technologies (NYSE:SXT) Has Affirmed Its Dividend Of $0.41

Biotech Stock Roundup: GILD Down on Study Results, INBX Gains on Sanofi Deal & More
INBX

Zacks

a year ago

Biotech Stock Roundup: GILD Down on Study Results, INBX Gains on Sanofi Deal & More

Inhibrx, Inc. (INBX) Soars 8.9%: Is Further Upside Left in the Stock?
INBX

Zacks

a year ago

Inhibrx, Inc. (INBX) Soars 8.9%: Is Further Upside Left in the Stock?

Health Care Roundup: Market Talk
INBX

The Wall Street Journal

a year ago

Health Care Roundup: Market Talk

These Stocks Moved the Most Today: United, 3M, Verizon, Plug Power, Johnson & Johnson, GE, and More
INBX

Barrons.com

a year ago

These Stocks Moved the Most Today: United, 3M, Verizon, Plug Power, Johnson & Johnson, GE, and More

Inhibrx Soared 176% Over Two Months — Now, Sanofi Is Buying It
INBX

Investor's Business Daily

a year ago

Inhibrx Soared 176% Over Two Months — Now, Sanofi Is Buying It

Inhibrx (INBX) Up 6% on Sale of Rare Disease Drug to Sanofi
INBX

Zacks

a year ago

Inhibrx (INBX) Up 6% on Sale of Rare Disease Drug to Sanofi

Survey Reveals 55% of CXM Leaders Plan to Invest $1 Million or more in GenAI in Next 12-18 Months
INBX

Business Wire

a year ago

Survey Reveals 55% of CXM Leaders Plan to Invest $1 Million or more in GenAI in Next 12-18 Months

Sanofi to buy Inhibrx in deal worth up to $2.2B
INBX

BioPharma Dive

a year ago

Sanofi to buy Inhibrx in deal worth up to $2.2B

Is CNO Financial Group (CNO) Stock Undervalued Right Now?
INBX

Zacks

a year ago

Is CNO Financial Group (CNO) Stock Undervalued Right Now?

Crinetics Pharmaceuticals Inc Insider Sells Shares
INBX

GuruFocus.com

a year ago

Crinetics Pharmaceuticals Inc Insider Sells Shares

A Closer Look At Atlantica Sustainable Infrastructure plc's (NASDAQ:AY) Uninspiring ROE
INBX

Simply Wall St.

a year ago

A Closer Look At Atlantica Sustainable Infrastructure plc's (NASDAQ:AY) Uninspiring ROE

Main Street Capital (MAIN) Increases Yet Falls Behind Market: What Investors Need to Know
INBX

Zacks

a year ago

Main Street Capital (MAIN) Increases Yet Falls Behind Market: What Investors Need to Know

Arbor Realty Trust (ABR) Ascends But Remains Behind Market: Some Facts to Note
INBX

Zacks

a year ago

Arbor Realty Trust (ABR) Ascends But Remains Behind Market: Some Facts to Note

SiTime to Present at the Needham Growth Conference on January 16, 2024
INBX

GlobeNewswire

a year ago

SiTime to Present at the Needham Growth Conference on January 16, 2024

What Is Nova Ltd.'s (NASDAQ:NVMI) Share Price Doing?
INBX

Simply Wall St.

a year ago

What Is Nova Ltd.'s (NASDAQ:NVMI) Share Price Doing?

Is Array Technologies Stock a Top Buy on the Dip in 2024?
INBX

Motley Fool

a year ago

Is Array Technologies Stock a Top Buy on the Dip in 2024?

Is There Now An Opportunity In Rapid7, Inc. (NASDAQ:RPD)?
INBX

Simply Wall St.

a year ago

Is There Now An Opportunity In Rapid7, Inc. (NASDAQ:RPD)?

Brookfield Acknowledges Result of the Origin Energy Shareholder Vote
INBX

GlobeNewswire

a year ago

Brookfield Acknowledges Result of the Origin Energy Shareholder Vote

Here's Why Prestige Consumer Healthcare (PBH) is a Strong Value Stock
INBX

Zacks

2 years ago

Here's Why Prestige Consumer Healthcare (PBH) is a Strong Value Stock

Apple Hospitality REIT Reports Results of Operations for Third Quarter 2023
INBX

Business Wire

2 years ago

Apple Hospitality REIT Reports Results of Operations for Third Quarter 2023

Privia Health Group, Inc.'s (NASDAQ:PRVA) P/S Still Appears To Be Reasonable
INBX

Simply Wall St.

2 years ago

Privia Health Group, Inc.'s (NASDAQ:PRVA) P/S Still Appears To Be Reasonable

Share on Social Networks: